In a poster at ASH 2025, Dr Fabio Andreozzi, hematologist, presented the...
At ASH 2025, quality-of-life (QoL) data of this trial were presented,...
Cohort 3 of the phase II ZUMA-2 trial has been designed to evaluate the safety...
In a poster at ASH 2025, Hatice Satilmis (Vrije Universiteit Brussel) presented...
At ASH 2025, Prof Dr Manali Kamdar presented the four-year follow-up results...
An analysis presented as a poster at ASH 2025 evaluated the impact of omitting...
In this light, Dr Enrique Ocio, presented the results of an analysis looking...
During ASH 2025, Dr Gabriel Brisou presented updated, real-world data on the...
During the 2025 IMS meeting, Prof Dr Marie-Christiane Vekemans shared the...
During IMS 2025, Prof Dr Vania Hungria presented the results of a subgroup...